News & Press Releases

Access the latest news about Lipidor, our current projects, publications and collaborations. Thank you for your interest in Lipidor!

Subscribe

January 24, 2024

Lipidor completes SEK 1.7 million sale of animal segment patent

STOCKHOLM, Sweden, 24th January 2024 – Lipidor AB (publ) (Nasdaq First North Growth Market: LIPI) today announces that one of the company's patents, previously out-licensed to Emollivet AB, has now been sold to the same party. The sale is aimed at strengthening Lipidor's short term cash position. Since its inception…

August 23, 2022

All patients in Lipidor’s Phase III study with psoriasis candidate AKP02 have completed treatment

STOCKHOLM, Sweden – Lipidor AB (publ) (Nasdaq First North Growth Market: LIPI) announces today that all patients included in the company's Phase…

July 11, 2022

Lipidor’s Phase III study of AKP02 for treatment of psoriasis now fully recruited, results expected Q3 2022

Lipidor AB (publ) (Nasdaq First North Growth Market: LIPI) can today announce that the last patient has been enrolled in the ongoing…

June 2, 2022

Bulletin from the annual general meeting of Lipidor AB (publ)

The following resolutions were passed at the annual general meeting (the “AGM”) of Lipidor AB (publ) (“the Company”) on 2 June. The…

May 20, 2022

Lipidor updates on Phase III study of AKP02 in treatment of psoriasis – half of patients now recruited

STOCKHOLM, Sweden, 20 May 2022 – Lipidor AB (publ) (Nasdaq First North Growth Market: LIPI) announces that half of the patients have…

May 5, 2022

Lipidor AB (publ) publishes interim report for first quarter 2022

STOCKHOLM, Sweden, 5 May 2022 – Today, Lipidor AB (publ) (Nasdaq First North Growth Market: LIPI) publishes its interim report for the…

May 3, 2022

NOTICE OF ANNUAL GENERAL MEETING IN LIPIDOR AB (publ)

STOCKHOLM, Sweden, 3[rd] May 2022: The shareholders of Lipidor AB (publ) reg. no. 556779-7500 (“Lipidor” or the “Company”) are hereby given notice…

April 28, 2022

Lipidor AB (publ) publishes annual report for 2021

STOCKHOLM, Sweden, 28th April 2022 – Today, Lipidor AB (publ) (Nasdaq First North Growth Market: LIPI) publishes its annual report for the…

March 25, 2022

Lipidor strengthens its operational team and recruits Supply Chain & Operations Manager

STOCKHOLM, Sweden, 25 March 2022 – Lipidor AB (publ) (Nasdaq First North Growth Market: LIPI) is announcing that the company has strengthened…

February 23, 2022

Lipidor AB (publ) publishes year-end report for 2021

STOCKHOLM, Sweden, 23 February 2022 – Today, Lipidor AB publishes its year-end report for the period 1 January – 31 December 2021.

January 26, 2022

Lipidor Announces Enrolment of First Patients in a Phase III Study on AKP02 for Treatment of Psoriasis

STOCKHOLM, Sweden, 26[th] January 2022 – Lipidor AB (publ) (Nasdaq First North Growth Market: LIPI) today reports that the first patients have…